Abstract
Objectives: This study aimed to explore the spectrum of CT brain findings in COVID-19 patients presenting with neurological symptoms and to evaluate their association with age and underlying comorbidities.
Methods: A retrospective review was conducted on 60 RT-PCR–confirmed COVID-19 patients who underwent CT brain at Lady Reading Hospital, Peshawar, from March to November 2021 due to neurological complaints such as altered mental status, headache, seizures, or focal deficits. Patient data, including demographics, comorbid conditions, and imaging findings, were collected. Data was analysed using descriptive and inferential statistics.
Results: The most frequent abnormality observed was ischemic infarction, present in 40% of patients, with a clear predominance among elderly individuals and those with comorbidities such as hypertension and diabetes mellitus. Brain atrophy was identified in 11.7% of cases, while intracranial haemorrhage was noted in 10%. Other, less common findings included hypoxic changes and nonspecific white matter abnormalities. Statistical testing revealed significant associations between age groups, comorbidity status, and occurrence of ischemic or hemorrhagic events (p < 0.05).
Conclusion: CT brain imaging in COVID-19 patients with neurological manifestations demonstrated a high frequency of structural abnormalities, particularly vascular insults. These findings suggest that SARS-CoV-2 infection may exacerbate cerebrovascular vulnerability in older and comorbid populations. Early neuroimaging in such patients is crucial for timely diagnosis and management. Further large-scale prospective studies are warranted to validate these associations and to guide neuroimaging protocols in severe COVID-19.
Keywords: COVID-19, Computed Tomography of Brain, Neurologic Manifestations, Cerebral Infarction, Hypertension
References
Choi Y, Lee MK. Neuroimaging findings of brain MRI and CT in patients with COVID-19: A systematic review and meta-analysis. European journal of radiology. 2020 Dec 1;133:109393. doi.org/10.1016/j.ejrad.2020.109393
Brauer T, Paika S, Kotwani R, Khanna D. Neurological Complications of COVID-19 Infection: A Comprehensive Review. Cureus. 2024 Jul 23;16(7). DOI: 10.7759/cureus. 65192
Carod-Artal FJ. Complicaciones neurológicas por coronavirus y COVID-19. Rev Neurol. 2020 Jan 1;70(9):311-22.
Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, Qiu Y, Wang J, Liu Y, Wei Y, Xia JA. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. The Lancet. 2020 Feb 15;395(10223):507-13.
Chou SH, Beghi E, Helbok R, Moro E, Sampson J, Altamirano V, Mainali S, Bassetti C, Suarez JI, McNett M, Nolan L. Global incidence of neurological manifestations among patients hospitalised with COVID-19—a report for the GCS-NeuroCOVID consortium and the ENERGY consortium. JAMA Network Open. 2021 May 3;4(5):e2112131-. doi:10.1001/jamanetworkopen.2021.12131
Widyadharma IP, Hendellyn A, Laksmi Dewi AP, Adnyana IM, Samatra DP, Utami DK. Neurologic manifestations of COVID-19 infection in Asia: a systematic review. The Egyptian Journal of Neurology, Psychiatry and Neurosurgery. 2021 Feb 17;57(1):28. doi.org/10.1186/s41983-021-00279-3
Mao L, Jin H, Wang M, Hu Y, Chen S, He Q, Chang J, Hong C, Zhou Y, Wang D, Miao X. Neurologic manifestations of hospitalised patients with coronavirus disease 2019 in Wuhan, China. JAMA Neurology. 2020 Jun 1;77(6):683-90. doi:10.1001/jamaneurol 2020.1127
Moonis G, Filippi CG, Kirsch CF, Mohan S, Stein EG, Hirsch JA, Mahajan A. The spectrum of neuroimaging findings on CT and MRI in adults with COVID-19. American Journal of Roentgenology. 2021 Oct 25;217(4):959-74. doi.org/10.2214/AJR.20.24839
Aghagoli G, Gallo Marin B, Katchur NJ, Chaves-Sell F, Asaad WF, Murphy SA. Neurological involvement in COVID-19 and potential mechanisms: a review. Neurocritical care. 2021 Jun;34(3):1062-71. doi.org/10.1007/s12028-020-01049-4
Helms J, Kremer S, Merdji H, Clere-Jehl R, Schenck M, Kummerlen C, Collange O, Boulay C, Fafi-Kremer S, Ohana M, Anheim M. Neurologic features in severe SARS-CoV-2 infection. New England Journal of Medicine. 2020 Jun 4;382(23):2268-70. DOI: 10.1056/NEJMc2008597
Kandemirli SG, Dogan L, Sarikaya ZT, Kara S, Akinci C, Kaya D, Kaya Y, Yildirim D, Tuzuner F, Yildirim MS, Ozluk E. Brain MRI findings in patients in the intensive care unit with COVID-19 infection. Radiology. 2020 Oct;297(1):E232-5. doi.org/10.1148/radiol.2020201697
Brola W, Wilski M. Neurological consequences of COVID-19. Pharmacological Reports. 2022 Dec;74(6):1208-22. doi.org/10.1007/s43440-022-00424-6
Beghi E, Moro E, Davidescu EI, Popescu BO, Grosu O, Valzania F, Cotelli MS, Kiteva‐Trenchevska G, Zakharova M, Kovács T, Armon C. Comparative features and outcomes of major neurological complications of COVID‐19. European journal of neurology. 2023 Feb;30(2):413-33. doi.org/10.1111/ene.15617
Ellul MA, Benjamin L, Singh B, Lant S, Michael BD, Easton A, Kneen R, Defres S, Sejvar J, Solomon T. Neurological associations of COVID-19. The Lancet Neurology. 2020 Sep 1;19(9):767-83.
Liotta EM, Batra A, Clark JR, Shlobin NA, Hoffman SC, Orban ZS, Koralnik IJ. Frequent neurologic manifestations and encephalopathy‐associated morbidity in Covid‐19 patients. Annals of clinical and translational neurology. 2020 Nov;7(11):2221-30.doi.org/10.1002/acn3.51210
Oxley TJ, Mocco J, Majidi S, Kellner CP, Shoirah H, Singh IP, De Leacy RA, Shigematsu T, Ladner TR, Yaeger KA, Skliut M. Large-vessel stroke as a presenting feature of Covid-19 in the young. New England Journal of Medicine. 2020 May 14;382(20):e60. Doi.10.1056/NEJMc2009787
Yaghi S, Ishida K, Torres J, Mac Grory B, Raz E, Humbert K, Henninger N, Trivedi T, Lillemoe K, Alam S, Sanger M. SARS-CoV-2 and stroke in a New York healthcare system. Stroke. 2020 Jul;51(7):2002-11. doi.org/10.1161/STROKEAHA.120.030335
Wu Y, Xu X, Chen Z, Duan J, Hashimoto K, Yang L, Liu C, Yang C. Nervous system involvement after infection with COVID-19 and other coronaviruses. Brain, behavior, and immunity. 2020 Jul 1;87:18-22. doi.org/10.1016/j.bbi.2020.03.031
Liguori C, Pierantozzi M, Spanetta M, Sarmati L, Cesta N, Iannetta M, Ora J, Mina GG, Puxeddu E, Balbi O, Pezzuto G. Subjective neurological symptoms frequently occur in patients with SARS-CoV2 infection. Brain, behavior, and immunity. 2020 Aug 1;88:11-6. Doi.org/10.1016/j.bbi.2020.05.037
Faro SH, Manmatharayan A, Leiby B, Jain N, Mohamed FB, Talekar KS, Doshi A, Jambor I, Chang S, Finkelstein M, Kremer S. Neuroimaging findings in 4342 hospitalized COVID‐19 subjects: a multicenter report from the United States and Europe. Journal of Neuroimaging. 2023 Sep;33(5):752-63. doi.org/10.1111/jon.13140
Yoon BC, Buch K, Lang M, Applewhite BP, Li MD, Mehan WA, Leslie-Mazwi TM, Rincon SP. Clinical and neuroimaging correlation in patients with COVID-19. American Journal of Neuroradiology. 2020 Oct 1;41(10):1791-6. https://doi.org/10.3174/ajnr.A6717
Merkler AE, Parikh NS, Mir S, Gupta A, Kamel H, Lin E, Lantos J, Schenck EJ, Goyal P, Bruce SS, Kahan J. Risk of ischemic stroke in patients with coronavirus disease 2019 (COVID-19) vs patients with influenza. JAMA neurology. 2020 Nov 1;77(11):1366-72. doi:10.1001/jamaneurol.2020.2730
Gupta A, Madhavan MV, Sehgal K, Nair N, Mahajan S, Sehrawat TS, Bikdeli B, Ahluwalia N, Ausiello JC, Wan EY, Freedberg DE. Extrapulmonary manifestations of COVID-19. Nature medicine. 2020 Jul;26(7):1017-32. doi.org/10.1038/s41591-020-0968-3
Sawlani V, Scotton S, Nader K, Jen JP, Patel M, Gokani K, Denno P, Thaller M, Englezou C, Janjua U, Bowen M. COVID-19-related intracranial imaging findings: a large single-centre experience. Clinical radiology. 2021 Feb 1;76(2):108-16. doi.org/10.1016/j.crad.2020.09.002
Paranjpe I, Fuster V, Lala A, Russak AJ, Glicksberg BS, Levin MA, Charney AW, Narula J, Fayad ZA, Bagiella E, Zhao S. Association of treatment dose anticoagulation with in-hospital survival among hospitalized patients with COVID-19. Journal of the American College of Cardiology. 2020 Jul 7;76(1):122-4.
Lopes RD, Furtado RH, Macedo AV, Bronhara B, Damiani LP, Barbosa LM, de Aveiro Morata J, Ramacciotti E, de Aquino Martins P, de Oliveira AL, Nunes VS. Therapeutic versus prophylactic anticoagulation for patients admitted to hospital with COVID-19 and elevated D-dimer concentration (ACTION): an open-label, multicentre, randomised, controlled trial. The Lancet. 2021 Jun 12;397(10291):2253-63. Doi.: https://doi.org/10.1016/S0140-6736(21)01203-4

This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
Copyright (c) 2025 Nasreen Aman, Rukhsana Aziz

